Cognitive and Emotional Factors Relation to Treatment Adherence in Asthmatic Patients in Upper Egypt
NCT ID: NCT06200623
Last Updated: 2024-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
138 participants
OBSERVATIONAL
2024-01-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19
NCT04613245
Interrelation Between Bronchial Asthma and Smoking
NCT03207620
Motivational Interviewing for Medication Adherence in Asthma
NCT01132430
Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD
NCT06417931
Intervention to Improve Inhalative Adherence
NCT02386722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthmatic patients presented to respiratory outpatient clinic
All subjects will be subjected to Complete history taking including demographic data, residence, educational level, income level, and presence of first- or second-degree medical relative. The first onset age of asthma and duration of asthma will be recorded. Factors that can affect treatment adherence are collected as type and number of medications, cost, inclusion in the health insurance system, availability, asthma-related comorbidities, and choice of drug and device.
: To assess adherence we will use the Morisky Medication Adherence Scale (MMAS-8) as discussed above
To assess patient beliefs, we will use The Beliefs about Medicines Questionnaire as discussed above To obtain information on illness perception we will use The Brief Illness Perception Questionnaire (Brief IPQ) as discussed above To assess asthma control we will use the asthma control test as discussed above
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age ≥18y at the time of study enrollment.
3. Provider diagnosed asthma and prescribed maintenance ICS treatment and as needed bronchodilator for at least one month
Exclusion Criteria
2. Severe psychopathology (e.g., schizophrenia)
3. Apparent cognitive or language deficit
4. Patients with associated other chronic chest diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Entsar Hsanen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Entsar Hsanen
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Entsar H Mohamed, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cognitive and emotional factor
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.